Implementation of Bright Light Therapy ID
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Bright light therapy.
- Who it may be relevant to
- Registry conditions: Depressive Symptoms. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Netherlands
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Alleviation of Depressive Symptoms in People With Intellectual Disabilities
Overview
Many adults with intellectual disabilities (ID) have depressive symptoms, which negatively impact their quality of life. A lot of of the non-medicinal forms of treatment are not or hardly suitable for people with ID. Bright light therapy (BLT) seems to be a good option. Earlier research has shown that BLT is applicable in this group and seems promising in terms of reducing depressive symptoms, without serious side effects. In part 1 of this project we investigate the implementation of BLT at Amarant. We will take the lessons learned into part 2 of this project: the implementation of BLT at Abrona. We will evaluate this process and the outcomes.
Interventions
- Other Bright light therapy
for 2 weeks the patient will take place for a 10.000lux lamp for 20-30 minutes.
Primary outcome measures
- acceptability [Time frame: three times during study, 3-4 months in between]
- appropriateness [Time frame: three times during study, 3-4 months in between]
- feasibility of the intervention [Time frame: three times during study, 3-4 months in between]
- fidelity [Time frame: three times during study, 3-4 months in between]
- strategies [Time frame: three times during study, 3-4 months in between]
- Determinants [Time frame: three times during study, 3-4 months in between]
Secondary outcome measures (2)
- Depressive symptoms [Time frame: 1 year]
- Behaviour [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Involved in the implementation of BLT (staff) OR
- Involved in the prescription or application of BLT (staff/relatives) OR
- receiving BLT for their depressive symptoms (patients with ID)
- 18 years or older
- informed consent
Exclusion criteria
- n/a
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-only
Study locations
Netherlands · 1 center
- ErasmusMC — Rotterdam
Identifiers
NCT: NCT06215235 · Panama-10390 · Wouters